- Home
- BFS vs CTY Comparison
BFS vs CTY Comparison
Compare BFS & CTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFS | CTY |
|---|---|---|
| Founded | 1993 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 902.2M | 1.0B |
| IPO Year | 1996 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BFS | CTY |
|---|---|---|
| Price | $28.57 | $18.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $43.00 | N/A |
| AVG Volume (30 Days) | 121.8K | ★ 209.4K |
| Earning Date | 11-05-2026 | 11-19-2026 |
| Dividend Yield | ★ 8.19% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $289,843,000.00 | N/A |
| Revenue This Year | $7.44 | N/A |
| Revenue Next Year | $3.40 | N/A |
| P/E Ratio | $58.20 | ★ N/A |
| Revenue Growth | ★ 7.81 | N/A |
| 52 Week Low | $28.56 | $16.22 |
| 52 Week High | $38.42 | $22.65 |
Technical Indicators
Market Signals| Indicator | BFS | CTY |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 32.88 |
| Support Level | $28.56 | N/A |
| Resistance Level | $35.04 | $22.65 |
| Average True Range (ATR) | 0.65 | 1.76 |
| MACD | 0.03 | -0.44 |
| Stochastic Oscillator | 22.93 | 28.51 |
Price Performance
Historical ComparisonAbout BFS Saul Centers Inc.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.
About CTY City Therapeutics Inc. Common Stock
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.